# Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype

> **NCT01352559** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 1000 (estimated)

## Conditions studied

- Depression

## Interventions

- **DRUG:** responders
- **DRUG:** non-responders

## Key facts

- **NCT ID:** NCT01352559
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-11
- **Primary completion:** 2007-03
- **Final completion:** 2018-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2015-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352559, "Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01352559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*